Lichtenstein GR - Search Results

1

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: lichtenstein gr. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.

2

Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.

Lichtenstein GR. Lichtenstein GR. Inflamm Bowel Dis. 2001 May;7 Suppl 1:S23-9. doi: 10.1002/ibd.3780070506. Inflamm Bowel Dis. 2001. PMID: 11380040 Review.

3

Infliximab improves quality of life in patients with Crohn's disease.

Lichtenstein GR, Bala M, Han C, DeWoody K, Schaible T. Lichtenstein GR, et al. Inflamm Bowel Dis. 2002 Jul;8(4):237-43. doi: 10.1097/00054725-200207000-00001. Inflamm Bowel Dis. 2002. PMID: 12131606 Clinical Trial.

4

The effects of infliximab maintenance therapy on health-related quality of life.

Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. Feagan BG, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2003 Oct;98(10):2232-8. doi: 10.1111/j.1572-0241.2003.07674.x. Am J Gastroenterol. 2003. PMID: 14572573 Clinical Trial.

5

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

Lichtenstein GR, Yan S, Bala M, Hanauer S. Lichtenstein GR, et al. Am J Gastroenterol. 2004 Jan;99(1):91-6. doi: 10.1046/j.1572-0241.2003.04010.x. Am J Gastroenterol. 2004. PMID: 14687148 Clinical Trial.

6

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Rutgeerts P, et al. Among authors: lichtenstein gr. Gastroenterology. 2004 Feb;126(2):402-13. doi: 10.1053/j.gastro.2003.11.014. Gastroenterology. 2004. PMID: 14762776 Clinical Trial.

7

Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.

Lichtenstein GR, Cuffari C, Kane SV, Hanauer S, Present DH. Lichtenstein GR, et al. Inflamm Bowel Dis. 2004 Jul;10 Suppl 2:S11-21. doi: 10.1097/00054725-200407002-00003. Inflamm Bowel Dis. 2004. PMID: 15475769 No abstract available.

8

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.

Lichtenstein GR, Hanauer SB, Kane SV, Present DH. Lichtenstein GR, et al. Inflamm Bowel Dis. 2004 Jul;10 Suppl 2:S2-10. doi: 10.1097/00054725-200407002-00002. Inflamm Bowel Dis. 2004. PMID: 15475770 Review.

9

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Katz JA, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2004 Dec;99(12):2385-92. doi: 10.1111/j.1572-0241.2004.30186.x. Am J Gastroenterol. 2004. PMID: 15571587

10

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.

Feagan BG, Sandborn WJ, Baker JP, Cominelli F, Sutherland LR, Elson CO, Salzberg BA, Archambault A, Bernstein CN, Lichtenstein GR, Heath PK, Cameron S, Hanauer SB. Feagan BG, et al. Among authors: lichtenstein gr. Aliment Pharmacol Ther. 2005 Feb 15;21(4):373-84. doi: 10.1111/j.1365-2036.2005.02336.x. Aliment Pharmacol Ther. 2005. PMID: 15709987 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page